Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RENALYTIX PLC Director's Dealing 2021

Jun 25, 2021

7877_dirs_2021-06-25_1e2a5357-5c78-40f6-b694-cc64bff41c07.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 2249D

Renalytix PLC

25 June 2021

Renalytix plc 

("Renalytix" or the "Company")

Director/PDMR Dealing

The Company was informed that today, Fergus Fleming, Chief Technology Officer, completed the sale of 15,000 ordinary shares of 0.25 pence each ("Ordinary Shares") in the Company at a price of 1075 pence per share.

Following completion of the sale, Fergus Fleming is interested in  569,481 Ordinary Shares representing 0.79% of the current issued share capital of the Company.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Fergus Fleming
2 Reason for the notification
a) Position/status Chief Technology Officer
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Renalytix plc
b) LEI 213800NTOH3FK3WER551
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of  £0.0025 each
Identification code GB00BYWL4Y04
b) Nature of the transaction Sale of shares
c) Currency GBP
d) Price(s) and volume(s)
Price(s) Volume(s)
£10.75 15,000
e) Aggregated information
- Aggregated volume 15,000
- Price £161,250.00
f) Date of the transaction 25 June 2021
g) Place of the transaction London Stock Exchange

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHQELFLFQLLBBX